AMAG Crosses Above Average Analyst Target
February 16, 2018 at 09:32 AM EST
In recent trading, shares of AMAG Pharmaceuticals, Inc. (AMAG) have crossed above the average analyst 12-month target price of $17.40, changing hands for $17.90/share..